Ending the reign of short-acting β2-agonists in Australia?
Price, D., Jenkins, C., Hancock, K., Vella, R., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S. Z., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Novic, D., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Willet, B., Bateman, E. D., Beekman, M., Stewart, D.
Demographic and Clinical Characteristics of Patients with Severe Asthma in the Asian Pacific Region: data from the International Severe Asthma Registry (ISAR)
Lyu, J., Rhee, C. K., Tran, T. N., Katial, R., Martin, N., Peters, M., Denton, E., Upham, J. W., Bardin, P. G., Cochrane,, B., Middleton, P. G., Reynolds, P. M., Perng, D. W., Wang, H., Sheu, C., Tsai, M., Wan-Chun Huang, E., Chien, Y., Hsu, J., Fu, P., Lin, C., Lin, S., Shen, S., Liu, S., Lee, K., Chiu, K., Lin, H., Lin, M., Chou, C., Salvi, S., Cho, Y. S., Yoo, K. H., Iwanaga, T., Tohda, Y., Fujimoto, H., Tanaka, H., Nogami, K., Sekiya, K., Matsunaga, M., Soichiro, H., Fujisawa, T., Nagano, T., Kobayashi, T., Oguma, T., Nishimura, Y., Murray, R. B., Bulathsinhala, L., Joshi, I., Eleangovan, N., Skinner, D., Carter, V., Price, C., Price, D.
Dupilumab sustains improvements in clinical efficacy and reductions in OCS use in patients with severe, OCS-dependent asthma: LIBERTY ASTHMA TRAVERSE study
Park, H. Y., Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Ending the reign of short-acting β2-agonists in Australia?
Price, D., Jenkins, C., Hancock, K., Vella, R., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Novic, D., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Willet, B., Bateman, E. D.
The association of short acting β2-agonist overuse with asthma control and severe exacerbations: an Australian perspective
Price, D., Jenkins, C., Hancock, K., Hancock, K., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Bateman, E. D.
Effect of stepping up to high-dose inhaled corticosteroids in patients with asthma: UK Database Study
Pavord, I. D., Tran, T. N., Jones, R., Nuevo, J., van den Berge, M., Brusselle, G., Menzies-Gow, A., Skinner, D., Carter, V., Kocks, J. W. H., Price, D.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 2, pp. 532-543
Sustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
An observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
Heatley, H., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Skinner, D., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
Clinical recommendations for dry powder inhaler use in the management of COPD in primary care
Leving, M., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Román-Rodríguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Usmani, O., Kocks, J.
npj Primary Care Respiratory Medicine, vol. 32, 59
Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kerstjens, H. A., Roche, N., Singh, D., Vogelmeier, C. F., Şen, E., Delfini Cançado, J. E., Kots, M., Nudo, E., Barile, S., Georges, G.
Systemic Corticosteroids in Asthma: A Call to Action From World Allergy Organization and Respiratory Effectiveness Group
Bleecker, E. R., Al-Ahmad, M., Bjermer, L., Caminati, M., Walter Canonica, G., Kaplan, A., Papadopoulos, N. G., Roche, N., Ryan, D., Tohda, Y., Price, D.
World Allergy Organization Journal, vol. 15, no. 12, 100726
Adrenal function recovery after durable OCS-sparing with benralizumab in the PONENTE study
Menzies-Gow, A., Gurnell, M., Heaney, L. G., Corren, J., Bel, E. H., Maspero, J., Harrison, T., Jackson, D. J., Price, D., Lugogo, N., Kreindler, J., Burden, A., de Giorgio-Miller, A., Faison, S., Padilla, K., Martin, U. J., Garcia Gil, E., PONENTE Study Group
European Respiratory Journal, vol. 60, no. 6, 2103226
Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
Price, D., Burkill, S., Eileen, W., Wechsler, M. E., Denton, E., Tran, T. N., Martin, N., Katial, R., Barker, P., Maspero, J. F., Hew, M., Brusselle, G., Christoff, G., Sadatsafavi, M., Torres-Duque, C. A., Porsbjerg, C. M., Ulrik, C., Hansen, S., Altraja, A., Bourdin, A., Papadopoulos, N. G., Kostikas, K., Salvi, S., Costello, R. W., Puggioni, F., Iwanaga, T., Rhee, C. K., Al-Ahmad, M., Larenas-Linnemann, D., Fonseca, J. A., Cosio, B. G., Siyue, M. K., Kirenga, B., Sheu, C., Tsai, M., Mahboub, B., Busby, J., Heaney, L. G., Pfeffer, P. E., Patel, P. H., Hoyte, F. L., Liu, Y., Lyu, J., Goh, C., Uthaman, T., Henley, W., ISAR EMBER
European Respiratory Society (ERS) International Congress., 2814
Characterising the impact of sex on severe asthma (SA) in the UK Severe Asthma Registry (UKSAR)
Loewenthal, L., Busby, J., McDowell, R. D., Brown, T., Burhan, H., Chaudhuri, R., Dennison, P., Dodd, J. W., Doe, S., Faruqi, S., Gore, R., Idris, E., Jackson, D. J., Patel, M., Pantin, T., Pavord, I. D., Pfeffer, P. E., Price, D., Siddiqui, S., Heaney, L. G., Menzies-Gow, A.
European Respiratory Society (ERS) International Congress., 308
Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kerstjens, H. A., Roche, N., Singh, D., Vogelmeier, C. F., Şen, E., Delfini Cançado, J. E., Kots, M., Nudo, E., Barile, S., Georges, G.
European Respiratory Society (ERS) International Congress., pp. 1552
Patient-reported barriers to accepting a technological adherence package in the MAGNIFY trial
Dickens, A. P., Halpin, D. M., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J. F., Mastoridis, P., Mezzi, K., Davis, S., Price, D.
European Respiratory Society (ERS) International Congress., 3402
Persistent reductions in OCS use in patients with severe, OCS dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
Burkill, S., Porsbjerg, C. M., Bourdin, A., Tran, T. N., Martin, N., Katial, R., Barker, P., Wechsler, M. E., Maspero, J. F., Bosnic-Anticevich, S., Chung, L. P., Katsoulotos, G., Christoff, G., Popov, T. A., Sadatsafavi, M., Torres-Duque, C. A., Ulrik, C., Assing, K. D., Hansen, S., Altraja, A., Lehtimäki, L. A., Papadopoulos, N. G., Kostikas, K., Salvi, S., Costello, R. W., Puggioni, F., Iwanaga, T., Rhee, C. K., Al-Ahmad, M., Larenas-Linnemann, D., Fonseca, J. A., Amaral, R., Al-Lehebi, R., Perez de Llano, L., Kirenga, B., Tsai, M., Mahboub, B., Pfeffer, P. E., Henley, W., Liu, Y., Lyu, J., Goh, C., Uthaman, T., Price, D., ISAR IGNITE
European Respiratory Society (ERS) International Congress., 3305
Risk factors for corticosteroid- and antibiotic only-treated asthma attacks in the NOVELTY cohort
Couillard, S., Peterson, S., Bengtsson, T., van den Berge, M., Price, D., Beasley, R., Sadatsafavi, M., Janson, C., Papi, A., Belton, L., Fagerås, M., Müllerová, H., Pavord, I. D.
European Respiratory Society (ERS) International Congress., 2125
Effectiveness of initiating biologics in severe asthma patients with high steroid exposure
Chen, W., Tran, T. N., Sadatsafavi, M., Garcia Gil, E., Alacqua, M., Menzies-Gow, A., Heaney, L. G., Pfeffer, P. E., Maspero, J. F., Peters, M., Christoff, G., Bhutani, M., Torres-Duque, C. A., Ulrik, C., Altraja, A., Lehtimäki, L., Taillé, C., Papaioannou, A. I., Salvi, S., Costello, R. W., Canonica, G. W., Iwanaga, T., Al-Ahmad, M., Larenas-Linnemann, D., Kuna, P., Fonseca, J. A., Al-Lehebi, R., Siyue, M. K., Rhee, C. K., Perez de Llano, L., Jones, R. C., Perng, D. W., Eileen, W., Hoyte, F. L., Wong, N. C. B., Lyu, J., Ariti, C., Murray, R., Goh, C., Joshi, I., Eleangovan, N., Price, D., ISAR GLITTER Working Group
European Respiratory Society (ERS) International Congress., 3405
P186 Facilitators to recruiting COPD patients to an adherence intervention trial
Dickens, A., Halpin, D., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J., Mastoridis, P., Mezzi, K., Davis, S., Vijaykumar, E., Price, D.
Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial
Dickens, A. P., Halpin, D. M., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J. F., Mastoridis, P., Mezzi, K., Davis, S., Vijaykumar, E., Price, D.
British Thoracic Society Winter Meeting 2022, pp. A72-A73
Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Characterization of patients in the International Severe Asthma Registry with high steroid exposure who did or did not initiate biologic therapy
Chen, W., Sadatsafavi, M., Tran, T. N., Murray, R. B., Wong, N. C. B., Ali, N., Ariti, C., Gil, E. G., Newell, A. P., Alacqua, M., Al-Ahmad, M., Altraja, H., Al-Lehebi, R., Bhutani, M., Bjermer, L., Bjerrum, A. S., Bourdin, A., Bulathsinhala, L., von Bülow, A., Busby, J., Canonica, G. W., Carter, V., Christoff, G., Cosio, B. G., Costello, R. W., FitzGerald, J. M., Fonseca, J. A., Yoo, K. H., Heaney, L. G., Heffler, E., Hew, M., Hilberg, O., Hoyte, F., Iwanaga, T., Jackson, D. J., Jones, R. C., Siyue, M. K., Kuna, P., Larenas-Linnemann, D., Lehmann, S., Lehtimäki, L. A., Lyu, J., Mahboub, B., Maspero, J. F., Menzies-Gow, A., Sirena, C., Papadopoulos, N. G., Papaioannou, A. I., Perez de Llano, L., Perng, D. W., Peters, M., Pfeffer, P. E., Porsbjerg, C. M., Popov, T. A., Rhee, C. K., Salvi, S., Taillé, C., Taube, C., Torres-Duque, C. A., Suppli Ulrik, C., Ra, S. W., Eileen, W., Wechsler, M. E., Price, D.
Journal of Asthma and Allergy, vol. 15, no. 15, pp. 1491—1510
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Deniz, Y., Siddiqui, S., Rowe, P.
AMCP Nexus 2022
Contributions to Conferences: Abstracts
Clinical outcomes in patients with severe asthma who had or had not initiated biologic therapy: results from the CLEAR study
Ali, N., Chen, S., Tran, T. N., Cook, B., Altraja, A., Bourdin, A., Sheu, C., Tsai, M., Hoyte, F. C. L., Quinton, A., Emmanuel, B., Goh, C. Y., Carter, V., Price, D.
Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy: results from the CLEAR study
Ali, N., Chen, S., Tran, T. N., Cook, B., Altraja, A., Bourdin, A., Sheu, C., Tsai, M., Hoyte, F. C. L., Quinton, A., Emmanuel, B., Goh, C. Y., Carter, V., Price, D.
Suboptimal peak inspiratory flow and critical inhalation errors are associated with higher COPD-related healthcare costs
Leving, M., van Boven, J. F., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Hartgers-Gubbels, E. S., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Kocks, J. W.
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 2401-2415
Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma
Stanley, B., Menzies-Gow, A., Bourdin, A., Canonica, G. W., Gurnell, M., Reddel, H., Heaney, L. G., Carter, V., Chapaneri, J., Tran, T. N., Maslova, E., Price, D.
European Respiratory Society (ERS) International Congress., 4420
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., JacobNara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
17th Annual Deutscher Allergiekongress (DAK) 2022, pp. 212
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry
Pace, W. D., Brandt, E., Carter, V. A., Chang, K., Edwards, C. L., Evans, A., Fox, C., Gaona, G., Han, M. K., Kaplan, A., Kent, R., Kocks, J. W. H., Kruszyk, M., Le Lievre, C. E., Li Voti, T., Mahle, C., Make, B., Ratigan, A. R., Shaikh, A., Skolnik, N., Stanley, B., Yawn, B. P., Price, D.
Annals of Family Medicine, vol. 20, no. 4, pp. 319-327
Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma
Stanley, B., Menzies-Gow, A., Bourdin, A., Canonica, G. W., Gurnell, M., Reddel, H. K., Heaney, L. G., Carter, V., Chapaner, J., Tran, T. N., Maslova, E., Maslova, E., Price, D.
European Respiratory Society (ERS) International Congress.
A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”
Menzies-Gow, A., Hoyte, F. L., Price, D. B., Cohen, D., Barker, P., Kreindler, J., Jison, M., Brooks, C. L., Papeleu, P., Katial, R.
Advances in Therapy, vol. 39, no. 8, pp. 3862-3865
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Aspen Allergy Conference – 40th Meeting
Contributions to Conferences: Abstracts
Persistent OCS reduction regardless of starting OCS dose in patients with severe, OCS-dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study
Cosio, B. G., Domingo, C., Gurnell, M., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
15º Congreso ALAT 2022
Contributions to Conferences: Abstracts
Characterisation of the Australian adult population living with asthma: Severe exacerbation frequency, long-term OCS use and adverse effects.
Hancock, K. L., Bosnic-Anticevich, S. Z., Blakey, J., Hew, M., Chung, L. P., Cvetkovski, B., Claxton, S., Del Fante, P., Denton, E., Doan, J., Ranasinghe, K., Morgan, L., Sharma, A., Smith, P. K., Stewart, D., Thompson, P. J., Wiseman, R., Upham, J. W., Yan, K. Y., Carter, V., Dhillon, K., Heraud, F., Le, T., Vella, R., Price, D.
Pragmatic and Observational Research, vol. 2022, pp. 43-58
Healthcare resource utilisation associated with intermittent oral corticosteroid use in asthma
Heatley, H., Tran, T. N., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Henley, W., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
2022 AANP National Conference
Contributions to Conferences: Posters
Let’s improve COPD prognosis: a practical tool for primary care providers to identify the frequency and follow-up of COPD lung attacks
Gerritsma, Y., Leving,, M., Dijk, L., van der Ham, I., Metz, B., Price, D., Salomé, P., Ställberg, B., Quint, J., Kocks, J.
Dutch Lung Congress 2022
Contributions to Conferences: Abstracts
Reply to: Cause or consequence?
Bateman, E. D., Price, D., Wang, H., Schonffeldt, P., Catanzariti, A., van der Valk, R. J., Beekman, M. J.
European Respiratory Journal, vol. 59, no. 6, 2200103
Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial
Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongste, J. C., Pijnenburg, M. W., Thomas, M., Price, D.
The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592
Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT
Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., Gaillard, E. A., de Jongeste, J., Pijnenburg, M. W., Thomas, M., Price, D.
Reducción persistente de corticosteroides orales independientemente de la dosis basal, en pacientes con asma córtico-dependiente tratados con dupilumab: Estudio Liberty Asthma-Traverse
Domingo, C., Gurnell, M., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
The 35th annual Eastern Allergy Conference, pp. S9
Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective
Bhutani, M., Price, D., Winders, T. A., Worth, H., Gruffydd-Jones, K., Tal-Singer, R., Correia de Sousa, J., Dransfield, M. T., Peché, R., Stolz, D., Hurst, J. R.
Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT
Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongeste, J., Pijnenburg, M. W., Thomas, M., Price, D.
Efficacy and Mechanism Evaluation, vol. 9, no. 4, pp. 1-153
Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers
W. H. Kocks, J., Wouters, H., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Dvortsin, E., Garcia Pardo, M., Gardev, A., Gawlik, R., van Geer - Postmus, I., van der Ham, I., Harbers, M., de la Hoz, A., Janse, Y., Kerkhof, M., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Leving, M. T.
npj Primary Care Respiratory Medicine, vol. 32, no. 1, 18
Evaluation of critical inhalation technique errors in patients with COPD on Dry Powder Inhaler maintenance therapy based on their association with health status: findings from the PIFotal study.
Kocks, J. W. H., Bosnic-Anticevich, S. Z., van Cooten, J., Correia de Sousa, J., Dekhuijzen, P. N. R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Janse, Y., Lavorini, F., Maricoto, T., Meije, J., Metz, B., Price, D., Rodríguez, M. R., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Voorham, J., Leving, M., Cvetkosvki, B.
Suboptimal peak inspiratory flow and inhalation technique errors are associated with higher COPD-relateD healthcare costs: results from the PIFotal COPD study
Leving, M., van Boven, J. F., Bosnic-Anticevich, S. Z., van Cooten, J., Correia de Sousa, J., Cvetkosvki, B., Dekhuijzen, P. N. R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Hartgers-Gubbels, L., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Kocks, J. W.
Adverse Outcomes Post-initiation of Systemic Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: A Long-term Observational UK-based Study
Price, D., Bafadhel, M., Papi, A., Carter, V., Tse, G., Ariti, C., Zhou, J., Skinner, D., Xu, X., Müllerová, H., Emmanuel, B.
Impact of initiating biologics in patients with severe asthma and on long-term oral corticosteroids or rescue steroids (GLITTER)
Chen, W., Tran, T. N., Sadatsafavi, M., Wong, N. C. B., Bulathsinhala, L., Gil, E. G., FitzGerald, J. M., Murray, R. B., Price, D., ISAR GLITTER Working Group
Persistent Reductions in OCS Use in Patients with Severe, OCS-Dependent Asthma Treated with Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Ribas, C. D., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Predicting Pneumonia events in COPD patients using medical records
Price, D., Henley, W., Carter, V., Skinner, D., Alexander, L., Vella, R., Papi, A., Fabbri, L. M., Kerstjens, H. A., Roche, N., Singh, D., Vogelmeier, C. F., Şen, E., Delfini Cançado, J. E., Kots, M., Nudo, E., Barile, S., Georges, G.
Prevalence of comorbidities in adults with severe asthma: results from the International Severe Asthma Registry (ISAR)
Scelo, G., Porsbjerg, C. M., Carter, V., Ariti, C., Lyu, J., Eleangovan, N., Tran, T. N., Baker, P., Katial, R., Martin, N., Altraja, A., Rhee, C. K., FitzGerald, J. M., Hansen, S., Heaney, L. G., Hew, M., Siyue, M. K., Pfeffer, P. E., Puggioni, F., Tsai, M., von Bülow, A., Eileen, W., Price, D., ISAR PRISM Working Group
Prototype ORACLE Score Validation in NOVELTY: Predicted versus Observed Asthma Exacerbation Rates
Couillard, S., Peterson, S., Bengtsson, T., van den Berge, M., Price, D., Beasley, R., Sadatsafavi, M., Janson, C., Belton, L., Fagerås, M., Müllerová, H., Pavord, I. D.
Relationships Between Symptoms and Lung Function in Asthma and/or Chronic Obstructive Pulmonary Disease in the NOVELTY study
Papi, A., Hughes, R., Olmo, R. d., Agusti, A., Chipps, B. E., Make, B., Tomaszewski, E., Peres Da Costa, K., Srivastava, D., Vestbo, J., Janson, C., Burgel, P., Price, D.
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma
Porsbjerg, C. M., Menzies-Gow, A., Tran, T. N., Murray, R. B., Unni, B., Ang, S. L. A., Alacqua, M., Al-Ahmad, M., Al-Lehebi, R., Altraja, A., Belevskiy, A. S., Björnsdóttir, U. S., Bourdin, A., Busby, J., Walter Canonica, G., Christoff, G., Cosio, B. G., Costello, R. W., FitzGerald, J. M., Fonseca, J. A., Hansen, S., Heaney, L. G., Heffler, E., Hew, M., Iwanaga, T., Jackson, D. J., Kocks, J. W. H., Kallieri, M., Bruce Ko, H., Siyue, M. K., Larenas-Linnemann, D., Lehtimäki, L. A., Loukides, S., Lugogo, N., Maspero, J. F., Papaioannou, A. I., Perez de Llano, L., Márcio Pitrez, P., Popov, T. A., Rasmussen, L. M., Rhee, C. K., Sadatsafavi, M., Schmidt, J., Siddiqui, S., Taillé, C., Taube, C., Torres-Duque, C. A., Ulrik, C., Upham, J. W., Eileen, W., Wechsler, M. E., Bulathsinhala, L., Carter, V., Chaudhry, I., Eleangovan, N., Hosseini, N., Rowlands, M., Price, D., van Boven, J. F.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 5
Variation in demographic and clinical characteristics of Patients with COPD receiving care in U.S. primary care: data from the Advancing the Patient EXperience (APEX) in COPD registry
Fox, C., Pace, W. D., Brandt, E., Chang, K., Edwards, C. L., Evans, A., Gaona, G., Han, M. K., Kaplan, A., Kent, R., Kocks, J. W., Kruszyk BEng, M., Le Lievre, C. E., Li Voti, T., Mahle, C., Make, B., Ratigan, A. R., Shaikh, A., Skolnik, N., Stanley, B., Yawn, B. P., Price, D.
Pragmatic and Observational Research, vol. 2022, no. 13, pp. 17-31
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial. (BICS)
Cotton, S., Devereux, G., Abbas, H., Briggs, A. H., Campbell, K., Chaudhuri, R., Choudhury, G., Dawson, D., De Soyza, A., Fielding, S., Gompertz, S., Haughney, J., Lang, C. C., Lee, A., MacLennan, G., MacNee, W., McCormack, K., McMeekin, N., Mills, N. L., Morice, A., Norrie, J., Petrie, L., Price, D., Short, P., Vestbo, J., Walker, P., Wedzicha, J. A., Wilson, A., Lipworth, B. J.
Asthma exacerbation and steroid burden in Australian primary care
Price, D., Hancock, K. L., Bosnic-Anticevich, S., Blakey, J., Hew, M., Chung, L. P., Cvetkovski, B., Claxton, S., Del Fante, P., Denton, E., Doan, J., Ranasinghe, K., Morgan, L., Sharma, A., Smith, P. K., Feldman-Stewart, D., Thompson, P., Wiseman, R., Upham, J. W., Yan, K. Y., Carter, V., Dhillon, K., Heraud, F., Le, T., Vella, R., OPCA Improving Asthma outcomes in Australia Research Group
The Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022, pp. 194
No difference in pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus long-acting bronchodilators
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kertsjens, H., Roche, N., Singh, D., Vogelmeier, C., Sen, E., Cancado, J., Nudo, E., Barile, S., Georges, G.
The burden of intermittent oral corticosteroid use in asthma
Heatley, H., Tran, T. N., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Skinner, D., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
IPCRG 2022
Contributions to Conferences: Abstracts
Lower pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kertsjens, H., Roche, N., Singh, D., Vogelmeier, C., Sen, E., Cancado, J., Nudo, E., Barile, S., Georges, G.
The Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022, pp. 81
CONQUEST: a quality improvement program for defining and optimizing standards of care for modifiable high-risk COPD patients
Alves, L., Pullen, R., Hurst, J. R., Miravitlles, M., Carter, V., Chen, R., Couper, A., Dransfield, M., Evans, A., Hardjojo, A., Jones, D., Jones, R., Kerr, M., Kostikas, K., Marshall, J., Martinez, F. J., van Melle, M., van Melle, M., Murray, R. B., Muro, S., Nordon, C., Pollack, M., Price, C., Sharma, A., Singh, D., Winders, T. A., Price, D.
Patient Related Outcome Measures, vol. 2022, no. 13, pp. 53-68
Interclass difference in pneumonia risk in COPD patients initiating fixed dose inhaled treatment containing extrafine particle beclometasone versus fine particle fluticasone
Price, D., Henley, W., Delfini Cançado, J. E., Fabbri, L. M., Kerstjens, H. A., Papi, A., Roche, N., Şen, E., Singh, D., Vogelmeier, C., Barille, S., Nudo, E., Carter, V., Skinner, D., Vella, R., Georges, G.
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 355—370
Ethnic differences in severe asthma clinical care and outcomes: an analysis of United Kingdom primary and specialist care
Busby, J., Heaney, L. G., Brown, T., Chaudhuri, R., Dennison, P., Gore, R., Jackson, D. J., Mansur, A. H., Menzies-Gow, A., Message, S., Niven, R., Patel, M., Price, D., Siddiqui, S., Stone, R. A., Pfeffer, P. E., UK Severe Asthma Registry
The Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 2, pp. 495-505
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to move forward
Martinez, F. J., Agusti, A., Celli, B. R., Han, M. K., Allinson, J., Bhatt, S. P., Calverley, P., Chotirmall, S. H., Chowdhury, B., Darken, P., Da Silva, C. A., Donaldson, G., Dorinsky, P., Dransfield, M., Faner, R., Halpin, D. M., Jones, P., Krishnan, J. A., Locantore, N., Martinez, F. D., Müllerová, H., Price, D., Rabe, K. F., Reisner, C., Singh, D., Vestbo, J., Vogelmeier, C. F., Wise, R. A., Tal-Singer, R., Wedzicha, J. A.
American Journal of Respiratory and Critical Care Medicine, vol. 205, no. 3, pp. 275-287
Prioritising primary care respiratory research needs: results from the 2020 International Primary Care Respiratory Group (IPCRG) global e-Delphi exercise
Abdel-Aal, A., Lisspers, K., Williams, S., Adab, P., Adams, R., Agarwal, D., Barnard, A., Bouloukaki, I., van Boven, J. F., Chavannes, N., Dickens, A. P., van Gemert, F., Escarrer, M., Haroon, S., Kayongo, A., Kirenga, B., Kocks, J. W. H., Kotz, D., Newby, C., McNulty, C., Metting, E., Moral, L., Papadakis, S., Pinnock, H., Price, D., Ryan, D., Singh, S. J., Correia de Sousa, J., Ställberg, B., Szefler, S. J., Taylor, S. J., Tsiligianni, I., Turner, A., Weller, D., Yusuf, O. M., Tabyshova, A. K., Jordan, R. E.
npj Primary Care Respiratory Medicine, vol. 32, no. 1, pp. 6
Real world biologic use and switch patterns in severe asthma: data from the International Severe Asthma Registry and the US CHRONICLE Study
Menzies-Gow, A., McBrien, C., Unni, B., Porsbjerg, C. M., Al-Ahmad, M., Ambrose, C., Assing, K. D., von Bülow, A., Busby, J., Cosio, B. G., FitzGerald, J. M., Gil, E. G., Hansen, S., Heaney, L. G., Hew, M., Jackson, D. J., Kallieri, M., Loukides, S., Lugogo, N., Papaioannou, A. I., Larenas-Linnemann, D., Moore, W. C., Perez de Llano, L., Rasmussen, L. M., Schmidt, J., Siddiqui, S., Alacqua, M., Tran, T. N., Suppli Ulrik, C., Upham, J. W., Eileen, W., Bulathsinhala, L., Carter, V. A., Chaudhry, I., Eleangovan, N., Murray, R. B., Price, C., Price, D.
Measuring peak inspiratory flow in patients with chronic obstructive pulmonary disease
Ohar, J. A., Ferguson, G. T., Mahler, D. A., Drummond, M. B., Dhand, R., Pleasants, R. A., Anzueto, A., Halpin, D. M., Price, D. B., Drescher, G. S., Hoy, H. M., Haughney, J., Hess, M. W., Usmani, O. S.
International journal of chronic obstructive pulmonary disease , vol. 17, pp. 79-92
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study
Menzies-Gow, A., Gurnell, M., Heaney, L. G., Corren, J., Bel, E. H., Maspero, J., Harrison, T., Jackson, D. J., Price, D., Lugogo, N., Kreindler, J., Burden, A., de Giorgio-Miller, A., Padilla, K., Martin, U. J., Garcia Gil, E.
The Lancet Respiratory Medicine, vol. 10, no. 1, pp. 47-58
Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
European Respiratory Society (ERS) International Congress., 3620
Facilitators to recruiting COPD patients to an adherence intervention trial
Dickens, A. P., Halpin, D. M., Carter, V., Skinner, D., Beeh, K., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J. F., Mastoridis, P., Mezzi, K., Davis, S., Vijaykumar, E., Price, D.
Sufficient inspiratory effort for a dry powder inhaler - do we have to measure it, or can we observe it?: Post hoc analysis of the PIFotal study.
Leving, M., Bosnic-Anticevich, S. Z., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, P. N. R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Zijlema, W., Kocks, J. W. H.
European Respiratory Journal, vol. 60, no. suppl 66, 2052
